THESEUS PHARMACEUTICALS, INC. Stock-Based Compensation
THESEUS PHARMACEUTICALS, INC. reported Stock-Based Compensation of $10.21 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2023-11-17
- THESEUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $3.64M, a 102.22% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $3.57M, a 41.90% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $2.99M, a 46.43% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $2.38M, a 49.94% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $11.41M, a 161.68% increase from fiscal 2021.
- THESEUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $4.36M, a 314.54% increase from fiscal 2020.
- THESEUS PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $1.05M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $7.21M derived: sum of 2 quarters · filed 2023-11-17 | $10.21M 10-Q · filed 2023-11-17 | $12.58M derived: sum of 4 quarters · filed 2023-11-17 | |
| 2023-06-30 | $3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $6.57M 10-Q · filed 2023-08-10 | $8.94M derived: sum of 3 quarters · filed 2023-08-10 | $10.74M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2023-03-31 | $2.99M 10-Q · filed 2023-05-11 | $5.37M derived: sum of 2 quarters · filed 2023-05-11 | $7.17M derived: sum of 3 quarters · filed 2023-05-11 | $9.69M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $4.17M derived: sum of 2 quarters · filed 2023-03-09 | $6.69M derived: sum of 3 quarters · filed 2023-08-10 | $11.41M 10-K · filed 2023-03-09 | |
| 2022-09-30 | $1.80M 10-Q · filed 2022-11-03 | $4.32M derived: sum of 2 quarters · filed 2023-08-10 | $9.04M 10-Q · filed 2023-11-17 | $7.95M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $4.56M 10-Q · filed 2023-08-10 | $6.15M derived: sum of 3 quarters · filed 2023-08-10 | $7.44M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $2.04M 10-Q · filed 2023-05-11 | $3.63M derived: sum of 2 quarters · filed 2023-05-11 | $4.92M derived: sum of 3 quarters · filed 2023-05-11 | $5.42M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.88M derived: sum of 2 quarters · filed 2023-03-09 | $3.38M derived: sum of 3 quarters · filed 2023-03-09 | $4.36M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.79M derived: sum of 2 quarters · filed 2022-11-03 | $2.78M 10-Q · filed 2022-11-03 | $3.08M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $500.00K 10-Q · filed 2022-11-03 | -$500.00K 10-Q · filed 2022-05-12 | $1.48M 10-Q · filed 2022-08-11 | $1.78M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-03-31 | $500.00K 10-Q · filed 2022-11-03 | $548.00K 10-Q · filed 2022-05-12 | $1.28M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2020-12-31 | $784.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.05M 10-K · filed 2022-03-10 | |||
| 2020-09-30 | $268.00K 10-Q · filed 2021-11-15 |